dm+d

38314008

Articles

Safety in Lactation: Acne and rosacea

30 October 2020Topical preparations for acne are considered to pose a negligible risk to a breastfeeding infant as long as precautions are taken to avoid contact of…

What issues should be considered in patients with peanut allergy requiring a medicine containing soya?

16 October 2020Peanut and soya belong to the same plant family, so there is concern about cross-sensitivity. This Medicines Q&A (updated April 2020) discusses the issues to…

What is the most suitable treatment for acne in a person with acute porphyria?

10 January 2020Topical (applied to the skin) treatments for acne are considered to be safer than oral treatments in people with an acute form of porphyria, provided…
Search Articles

Medicine Compliance Aid Stability

RoaccutaneRoche Products Ltd

Roche Products Ltd
Roaccutane
Capsules soft 10mg, 20mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Soft capsules.
24 September 2015

Lactation Safety Information

Topical acne preparations
Long half-life increases risk of accumulation in breastfed infants
No published evidence of safety for oral use
Risk to breastfed infant unknown but high risk of foetal damage if mother is not following contraception guidelines - see summary
22 September 2020
Other topical acne preparations
Minimal systemic absorption by mother - see summary
22 September 2020